Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells
Tumor-initiating cells, also designated as cancer stem cells, are proposed to constitute a subpopulation of malignant cells central to tumorigenesis, metastasis, and treatment resistance. We analyzed the activity of the proteasome, the primary organelle for targeted protein degradation, as a marker...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-08-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2015.00016 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841563084293931008 |
---|---|
author | Amanda C. Stacer Hanxiao Wang Joseph Fenner Joseph S. Dosch Anna Salomonnson Kathryn E. Luker Gary D. Luker Alnawaz Rehemtulla Brian D. Ross |
author_facet | Amanda C. Stacer Hanxiao Wang Joseph Fenner Joseph S. Dosch Anna Salomonnson Kathryn E. Luker Gary D. Luker Alnawaz Rehemtulla Brian D. Ross |
author_sort | Amanda C. Stacer |
collection | DOAJ |
description | Tumor-initiating cells, also designated as cancer stem cells, are proposed to constitute a subpopulation of malignant cells central to tumorigenesis, metastasis, and treatment resistance. We analyzed the activity of the proteasome, the primary organelle for targeted protein degradation, as a marker of tumor- and metastasis-initiating cells. Using human and mouse breast cancer cells expressing a validated fluorescent reporter, we found a small subpopulation of cells with low proteasome activity that divided asymmetrically to produce daughter cells with low or high proteasome activity. Breast cancer cells with low proteasome activity had greater local tumor formation and metastasis in immunocompromised and immunocompetent mice. To allow flexible labeling of cells, we also developed a new proteasome substrate based on HaloTag technology. Patient-derived glioblastoma cells with low proteasome activity measured by the HaloTag reporter show key phenotypes associated with tumor-initiating cells, including expression of a stem cell transcription factor, reconstitution of the original starting population, and enhanced neurosphere formation. We also show that patient-derived glioblastoma cells with low proteasome activity have higher frequency of tumor formation in mouse xenografts. These studies support proteasome function as a tool to investigate tumor- and metastasis-initiating cancer cells and a potential biomarker for outcomes in patients with several different cancers. |
format | Article |
id | doaj-art-150fc92789d444349a002a256c115e9d |
institution | Kabale University |
issn | 1536-0121 |
language | English |
publishDate | 2015-08-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Molecular Imaging |
spelling | doaj-art-150fc92789d444349a002a256c115e9d2025-01-03T00:12:14ZengSAGE PublishingMolecular Imaging1536-01212015-08-011410.2310/7290.2015.0001610.2310_7290.2015.00016Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating CellsAmanda C. StacerHanxiao WangJoseph FennerJoseph S. DoschAnna SalomonnsonKathryn E. LukerGary D. LukerAlnawaz RehemtullaBrian D. RossTumor-initiating cells, also designated as cancer stem cells, are proposed to constitute a subpopulation of malignant cells central to tumorigenesis, metastasis, and treatment resistance. We analyzed the activity of the proteasome, the primary organelle for targeted protein degradation, as a marker of tumor- and metastasis-initiating cells. Using human and mouse breast cancer cells expressing a validated fluorescent reporter, we found a small subpopulation of cells with low proteasome activity that divided asymmetrically to produce daughter cells with low or high proteasome activity. Breast cancer cells with low proteasome activity had greater local tumor formation and metastasis in immunocompromised and immunocompetent mice. To allow flexible labeling of cells, we also developed a new proteasome substrate based on HaloTag technology. Patient-derived glioblastoma cells with low proteasome activity measured by the HaloTag reporter show key phenotypes associated with tumor-initiating cells, including expression of a stem cell transcription factor, reconstitution of the original starting population, and enhanced neurosphere formation. We also show that patient-derived glioblastoma cells with low proteasome activity have higher frequency of tumor formation in mouse xenografts. These studies support proteasome function as a tool to investigate tumor- and metastasis-initiating cancer cells and a potential biomarker for outcomes in patients with several different cancers.https://doi.org/10.2310/7290.2015.00016 |
spellingShingle | Amanda C. Stacer Hanxiao Wang Joseph Fenner Joseph S. Dosch Anna Salomonnson Kathryn E. Luker Gary D. Luker Alnawaz Rehemtulla Brian D. Ross Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells Molecular Imaging |
title | Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells |
title_full | Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells |
title_fullStr | Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells |
title_full_unstemmed | Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells |
title_short | Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells |
title_sort | imaging reporters for proteasome activity identify tumor and metastasis initiating cells |
url | https://doi.org/10.2310/7290.2015.00016 |
work_keys_str_mv | AT amandacstacer imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT hanxiaowang imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT josephfenner imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT josephsdosch imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT annasalomonnson imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT kathryneluker imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT garydluker imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT alnawazrehemtulla imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells AT briandross imagingreportersforproteasomeactivityidentifytumorandmetastasisinitiatingcells |